Literature DB >> 10495475

Glucose transport in brain and retina: implications in the management and complications of diabetes.

A K Kumagai1.   

Abstract

Neural tissue is entirely dependent on glucose for normal metabolic activity. Since glucose stores in the brain and retina are negligible compared to glucose demand, metabolism in these tissues is dependent upon adequate glucose delivery from the systemic circulation. In the brain, the critical interface for glucose transport is at the brain capillary endothelial cells which comprise the blood-brain barrier (BBB). In the retina, transport occurs across the retinal capillary endothelial cells of the inner blood-retinal barrier (BRB) and the retinal pigment epithelium of the outer BRB. Because glucose transport across these barriers is mediated exclusively by the sodium-independent glucose transporter GLUT1, changes in endothelial glucose transport and GLUT1 abundance in the barriers of the brain and retina may have profound consequences on glucose delivery to these tissues and major implications in the development of two major diabetic complications, namely insulin-induced hypoglycemia and diabetic retinopathy. This review discusses the regulation of brain and retinal glucose transport and glucose transporter expression and considers the role of changes in glucose transporter expression in the development of two of the most devastating complications of long-standing diabetes mellitus and its management. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10495475     DOI: 10.1002/(sici)1520-7560(199907/08)15:4<261::aid-dmrr43>3.0.co;2-z

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  29 in total

Review 1.  Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation?

Authors:  Muthuswamy Balasubramanyam; Rangasamy Sampathkumar; Viswanathan Mohan
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

Review 2.  In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro.

Authors:  R F Haseloff; I E Blasig; H C Bauer; H Bauer
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

3.  Administration of sesamol improved blood-brain barrier function in streptozotocin-induced diabetic rats.

Authors:  R L VanGilder; K A Kelly; M D Chua; R L Ptachcinski; Jason D Huber
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

4.  Assessment of cognitive status in patients with type 2 diabetes through the Mini-Mental Status Examination: a cross-sectional study.

Authors:  Renata C Alencar; Roberta A Cobas; Marília B Gomes
Journal:  Diabetol Metab Syndr       Date:  2010-01-28       Impact factor: 3.320

5.  An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment.

Authors:  Hao Wu; Ana R Rodriguez; Bernd W Spur; Venkat Venkataraman
Journal:  J Vis Exp       Date:  2016-09-13       Impact factor: 1.355

6.  Modulating GLUT1 expression in retinal pigment epithelium decreases glucose levels in the retina: impact on photoreceptors and Müller glial cells.

Authors:  Aditi Swarup; Ivy S Samuels; Brent A Bell; John Y S Han; Jianhai Du; Erik Massenzio; E Dale Abel; Kathleen Boesze-Battaglia; Neal S Peachey; Nancy J Philp
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-21       Impact factor: 4.249

7.  Activation of retinal Müller cells in response to glucose variability.

Authors:  Fabiana Picconi; Mariacristina Parravano; Francesca Sciarretta; Chiara Fulci; Michela Nali; Simona Frontoni; Monica Varano; Anna Maria Caccuri
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

8.  Evaluation of an immortalized retinal endothelial cell line as an in vitro model for drug transport studies across the blood-retinal barrier.

Authors:  Jie Shen; Stacy T Cross; Diane D S Tang-Liu; Devin F Welty
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

9.  Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.

Authors:  K Szabadfi; D Reglodi; A Szabo; B Szalontai; A Valasek; Gy Setalo; P Kiss; A Tamas; M Wilhelm; R Gabriel
Journal:  Neurotox Res       Date:  2016-01-06       Impact factor: 3.911

10.  Metabolic adaptations to interrupted glycosaminoglycan recycling.

Authors:  Josh C Woloszynek; Atilla Kovacs; Kevin K Ohlemiller; Marie Roberts; Mark S Sands
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.